Endosomal v-ATPase as a Sensor Determining Myocardial Substrate Preference

• Published in: Metabolites 2022-06, Vol.12 (7), p.579
• Main Authors: Wang, Shujin, Han, Yinying, Nabben, Miranda, Neumann, Dietbert, Luiken, Joost J. F. P., Glatz, Jan F. C.
• Format: Article
• Language: English
• Subjects: Acidification; Adenosine triphosphatase; Adenosine triphosphate; Amino acids; endosomal acidification; Energy; Energy requirements; Enzymes; Fatty acids; Functional foods & nutraceuticals; Glucose; H+-transporting ATPase; Heart; Heart diseases; Insulin; Insulin resistance; Ketones; Kinases; Ligands; lipid; Lipids; Mammals; Metabolism; Metabolites; Muscle contraction; Physiology; Plasma; Proteins; Protons; Review; Substrate preferences; Therapeutic targets; vacuolar-type H+-ATPase
• ISSN: 2218-1989; 2218-1989
• DOI: 10.3390/metabo12070579

The heart is a metabolically flexible omnivore that can utilize a variety of substrates for energy provision. To fulfill cardiac energy requirements, the healthy adult heart mainly uses long-chain fatty acids and glucose in a balanced manner, but when exposed to physiological or pathological stimuli, it can switch its substrate preference to alternative substrates such as amino acids (AAs) and ketone bodies. Using the failing heart as an example, upon stress, the fatty acid/glucose substrate balance is upset, resulting in an over-reliance on either fatty acids or glucose. A chronic fuel shift towards a single type of substrate is linked with cardiac dysfunction. Re-balancing myocardial substrate preference is suggested as an effective strategy to rescue the failing heart. In the last decade, we revealed that vacuolar-type H+-ATPase (v-ATPase) functions as a key regulator of myocardial substrate preference and, therefore, as a novel potential treatment approach for the failing heart. Fatty acids, glucose, and AAs selectively influence the assembly state of v-ATPase resulting in modulation of its proton-pumping activity. In this review, we summarize these novel insights on v-ATPase as an integrator of nutritional information. We also describe its exploitation as a therapeutic target with focus on supplementation of AA as a nutraceutical approach to fight lipid-induced insulin resistance and contractile dysfunction of the heart.